JasonGotlibMD

PubMed

• Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry.
  Marek Niedoszytko, Aleksandra Gorska, Knut Brockow, Patrizia Bonadonna, Magdalena Lange, Hanneke Kluin-Nelemans, Hanneke Oude-Elberink, Vito Sabato, Khalid Shoumariyeh...> ;Allergy. 2024 Apr 23
• Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM.
  Johannes Lübke, Alicia Schmid, Deborah Christen, Hanneke N G Oude Elberink, Lambert F R Span, Marek Niedoszytko, Aleksandra Górska, Magdalena Lange, Karoline V Gleixne...> ;Blood Advances. 2024 Apr 9
• World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.
  William Shomali, Jason Gotlib> ;American Journal of Hematology. 2024 May 1
• Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guide...
  Donal P McLornan, Tomasz Czerw, Gandhi Damaj, Mark Ethell, Carmelo Gurnari, Juan Carlos Hernández-Boluda, Nicola Polverelli, Juliana Schwaab, Katja Sockel, Greco Raffa...> ;Leukemia. 2024 Apr 1
• 5 citations
  The Normal Range of Baseline Tryptase Should Be 1 to 15 ng/mL and Covers Healthy Individuals With HαT.
  Peter Valent, Gregor Hoermann, Patrizia Bonadonna, Karin Hartmann, Wolfgang R Sperr, Sigurd Broesby-Olsen, Knut Brockow, Marek Niedoszytko, Olivier Hermine, Yannick Ch...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2023 Oct 1
• 2 citations
  Incidence of blast phase in myelofibrosis according to anemia severity.
  Barbara Mora, Margherita Maffioli, Elisa Rumi, Paola Guglielmelli, Marianna Caramella, Andrew Kuykendall, Francesca Palandri, Alessandra Iurlo, Valerio De Stefano, Jea...> ;Ejhaem. 2023 Aug 1
• Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery Approaches.
  Pramod C Nair, Jacob Piehler, Denis Tvorogov, David M Ross, Angel F Lopez, Jason Gotlib, Daniel Thomas> ;Blood Cancer Discovery. 2023 Sep 1
• Enkurin: a novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens.
  Sumanth Mosale Seetharam, Yi Liu, Jason Wu, Lenn Fechter, Kanagavel Murugesan, Holden Maecker, Jason Gotlib, James Zehnder, Ramasamy Paulmurugan, Anandi Krishnan> ;Blood Advances. 2023 Sep 26
• 10 citations
  The international consensus classification of eosinophilic disorders and systemic mastocytosis.
  Sa A Wang, Attilio Orazi, Jason Gotlib, Andreas Reiter, Alexandar Tzankov, Robert P Hasserjian, Daniel A Arber, Ayalew Tefferi> ;American Journal of Hematology. 2023 Aug 1
• 6 citations
  Avapritinib versus Placebo in Indolent Systemic Mastocytosis.
  Gotlib, J., Castells, M., Elberink, H., Siebenhaar, F., Hartmann, K., Broesby-Olsen, S., George, T., Panse, J., Alvarez-Twose, I., Radia, D., Tashi, T., Bulai Lividean...> ;NEJM Evidence. 2023 Jun 1
• 6 citations
  Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial.
  Srdan Verstovsek, Lynda Foltz, Vikas Gupta, Robert Hasserjian, Taghi Manshouri, John Mascarenhas, Ruben Mesa, Olga Pozdnyakova, Ellen Ritchie, Ivo Veletic, Katia Gamel...> ;Haematologica. 2023 Oct 1
• 2 citations
  Comprehensive response criteria for myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: a proposal from the MLN International Working Group.
  William Shomali, Philomena Colucci, Tracy I George, Jean-Jacques Kiladjian, Cheryl Langford, Jay L Patel, Andreas Reiter, Alessandro M Vannucchi, Jason Gotlib> ;Leukemia. 2023 May 1
• 1 citations
  Enkurin: A novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens.
  Sumanth Mosale Seetharam, Yi Liu, Jason Wu, Lenn Fechter, Kanagavel Murugesan, Holden Maecker, Jason Gotlib, James Zehnder, Ramasamy Paulmurugan, Anandi Krishnan> ;Biorxiv. 2023 Jan 12
• 12 citations
  Available and emerging therapies for bona fide advanced systemic mastocytosis and primary eosinophilic neoplasms.
  Jason Gotlib> ;Hematology. American Society of Hematology. Education Program. 2022 Dec 9
• Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis.
  Johannes Lübke, Juliana Schwaab, Deborah Christen, Hanneke Oude Elberink, Bart Span, Marek Niedoszytko, Aleksandra Gorska, Magdalena Lange, Karoline V Gleixner, Emir H...> ;The Journal of Allergy and Clinical Immunology. in Practice. 2023 Feb 1
• 30 citations
  Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes.
  Peter Valent, Amy D Klion, Florence Roufosse, Dagmar Simon, Georgia Metzgeroth, Kristin M Leiferman, Juliana Schwaab, Joseph H Butterfield, Wolfgang R Sperr, Karl Sotl...> ;Allergy. 2023 Jan 1
• MPN-352 Clinicopathologic and Molecular Correlates of Organ Damage Across the Spectrum of Advanced Systemic Mastocytosis.
  Emily Liang, Cecelia Perkins, Rong Lu, Hongliang Shi, Saša Dimitrijević, Gerard Hoehn, Justin Abuel, Cheryl Langford, Parveen Abidi, Lenn Fechter, William Shomali, Jas...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Oct 1
• MPN-435 Overall Survival in Patients With Systemic Mastocytosis With Associated Hematologic Neoplasm Treated With Avapritinib Versus Best Available Therapy.
  Andreas Reiter, Jason Gotlib, Iván Álvarez-Twose, Deepti Radia, Johannes Lübke, Priyanka Bobbili ScD, Aolin Wang, Chelsea Norregaard, Saša Dimitrijević, Erin Sullivan,...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Oct 1
• MPN-469 Rusfertide (PTG-300) Treatment Interruption Reverses Hematological Gains and Upon Reinitiation, Restoration of Clinical Benefit Observed in Patients With Polyc...
  Naveen Pemmaraju, Andrew Kuykendall, Marina Kremyanskaya, Yelena Ginzburg, Ellen Ritchie, Jason Gotlib, Aaron Gerds, Jeanne Palmer, Frank Valone, Paula O'Connor, Nishi...> ;Clinical Lymphoma, Myeloma & Leukemia. 2022 Oct 1
• 9 citations
  Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs.
  Jonas S Jutzi, Anna E Marneth, Michele Ciboddo, Angel Guerra-Moreno, María José Jiménez-Santos, Anastasia Kosmidou, James W Dressman, Hongyan Liang, Rebecca Hamel, Pat...> ;Blood. 2022 Sep 15
• 733 citations
  International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
  Daniel A Arber, Attilio Orazi, Robert P Hasserjian, Michael J Borowitz, Katherine R Calvo, Hans-Michael Kvasnicka, Sa A Wang, Adam Bagg, Tiziano Barbui, Susan Branford...> ;Blood. 2022 Sep 15
• 17 citations
  Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry.
  Vanessa E Kennedy, Cecelia Perkins, Andreas Reiter, Mohamad Jawhar, Johannes Lübke, Hanneke C Kluin-Nelemans, William Shomali, Cheryl Langford, Justin Abuel, Olivier H...> ;Blood Advances. 2023 May 9
• 30 citations
  Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
  Aaron T Gerds, Jason Gotlib, Haris Ali, Prithviraj Bose, Andrew Dunbar, Amro Elshoury, Tracy I George, Krishna Gundabolu, Elizabeth Hexner, Gabriela S Hobbs, Tania Jai...> ;Journal of the National Comprehensive Cancer Network. 2022 Sep 1
• 8 citations
  Prediction of thrombosis in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study on 1258 patients.
  Barbara Mora, Paola Guglielmelli, Andrew Kuykendall, Elisa Rumi, Margherita Maffioli, Francesca Palandri, Valerio De Stefano, Marianna Caramella, Silvia Salmoiraghi, J...> ;Leukemia. 2022 Oct 1
• 16 citations
  Efficacy of avapritinib versus best available therapy in the treatment of advanced systemic mastocytosis.
  Andreas Reiter, Jason Gotlib, Iván Álvarez-Twose, Deepti H Radia, Johannes Lübke, Priyanka J Bobbili, Aolin Wang, Chelsea Norregaard, Saša Dimitrijevic, Erin Sullivan,...> ;Leukemia. 2022 Aug 1
• Join now to see all